Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Avidity Biosciences, Inc. (RNA : NSDQ)
 
 • Company Description   
Avidity Biosciences Inc. is a biopharmaceutical company pioneering a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates(TM). The company's AOC platform design, engineer and develop therapeutics which combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide therapies. Its lead product candidate consist AOC 1001, is designed to treat myotonic dystrophy type 1,and other muscle programs are focused on the treatment of muscle atrophy, Duchenne muscular dystrophy, facioscapulohumeral muscular dystrophy and Pompe disease. Avidity Biosciences Inc. is based in SAN DIEGO.

Number of Employees: 125

 
 • Price / Volume Information   
Yesterday's Closing Price: $12.95 Daily Weekly Monthly
20 Day Moving Average: 264,353 shares
Shares Outstanding: 49.76 (millions)
Market Capitalization: $644.43 (millions)
Beta: 1.36
52 Week High: $29.59
52 Week Low: $11.02
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -24.05% -14.46%
12 Week -21.75% -13.98%
Year To Date -45.52% -34.97%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
10578 SCIENCE CENTER DRIVE SUITE 125
-
SAN DIEGO,CA 92121
USA
ph: 858-401-7900
fax: -
kath.gallagher@aviditybio.com http://www.aviditybiosciences.com
 
 • General Corporate Information   
Officers
Sarah Boyce - President; Chief Executive Officer and Director
Troy Wilson - Chairman
Michael F. MacLean - Chief Financial Officer
Carsten Boe - Director
Noreen Henig - Director

Peer Information
Avidity Biosciences, Inc. (CORR.)
Avidity Biosciences, Inc. (RSPI)
Avidity Biosciences, Inc. (CGXP)
Avidity Biosciences, Inc. (BGEN)
Avidity Biosciences, Inc. (GTBP)
Avidity Biosciences, Inc. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 05370A108
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/08/22
Share - Related Items
Shares Outstanding: 49.76
Most Recent Split Date: (:1)
Beta: 1.36
Market Capitalization: $644.43 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.75 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-3.07 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/08/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.72
Price/Cash Flow: -
Price / Sales: 76.56
EPS Growth
vs. Year Ago Period: -10.94%
vs. Previous Quarter: 13.41%
Sales Growth
vs. Year Ago Period: -33.62%
vs. Previous Quarter: -3.08%
ROE
03/31/22 - -36.26
12/31/21 - -35.57
09/30/21 - -30.60
ROA
03/31/22 - -32.81
12/31/21 - -32.36
09/30/21 - -28.06
Current Ratio
03/31/22 - 13.09
12/31/21 - 13.86
09/30/21 - 18.82
Quick Ratio
03/31/22 - 13.09
12/31/21 - 13.86
09/30/21 - 18.82
Operating Margin
03/31/22 - -1,525.48
12/31/21 - -1,265.38
09/30/21 - -995.70
Net Margin
03/31/22 - -1,525.48
12/31/21 - -1,265.38
09/30/21 - -995.70
Pre-Tax Margin
03/31/22 - -1,525.48
12/31/21 - -1,265.38
09/30/21 - -995.70
Book Value
03/31/22 - 7.55
12/31/21 - 8.13
09/30/21 - 8.42
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©